Trial Profile
The Effects of Exenatide on Post-Prandial Glucose Excursions and Vascular Health in Obese/Pre-Diabetic Young Adults.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Glucose intolerance; Obesity
- Focus Biomarker; Therapeutic Use
- 20 Feb 2009 New trial record